An FDA advisory panel released a preliminary review questioning results from a Phase 3 trial for Novo Nordisk’s IDegLira, an experimental diabetes treatment. It profoundly impacts the health of individual Mexicans and negatively affects the country’s socioeconomic development. In an oral presentation later today, the Company will review clinical and preclinical data of TTP273, the first small molecule, orally active, GLP-1 receptor agonist (GLP-1R), which is currently in Phase 2 studies. The idea behind MiniMed Connect is that the entire care team can have access to the patient’s diabetes data to make informed decisions to achieve better outcomes for the patient. The researchers describe a new data-driven approach to population health in which they use machine learning to develop predictive models and risk factors for the onset of type 2 diabetes. Challenges in delivering digital interventions for long-term conditions include integration of data between institutional and personal recorded sources to perform big data analytics and facilitating technology use in those with disabilities, low digital literacy, low socioeconomic status and in minority groups. His year of data lives not on monotone printouts and spreadsheets, but on sweeping, colorful graphs and charts that show highs, lows, and trends.
A lot of work has already been done with electronic health records (EHRs) in efforts to predict the existence of certain diseases. The team created a scoring scale